Eastern Journal of Medicine, vol.28, no.4, pp.832-835, 2023 (Scopus)
We report a unique case of superior mesenteric artery embolism that developed in a patient with COVID-19 who was followed up with the diagnosis of Fabry Disease. On the 12th day of COVID-19 illness, atrial fibrillation and superior mesenteric artery embolism were detected in a 56-year-old male patient who was previously diagnosed with Fabry Disease. We did not find a similar patient in the literature. In the coexistence of Fabry Disease and COVID-19, risk of arrhythmia such as atrial fibrillation, which is the most common arrhythmia in both diseases, increases further. COVID-19 can cause arterial and venous thrombosis. In the coexistence of Fabry Disease and COVID-19, care should be taken against increased thrombogenicity, arrhythmia (such as atrial fibrillation) and thromboembolism that may develop due to them.